Skip to content
healthcare.dev
Get a free key

BioThrax

NDC 64678-211, Anthrax Vaccine Adsorbed, injection, suspension, from Emergent BioDefense Operations Lansing, LLC.

Product NDC
64678-211
Status
Listed
Labeler
Emergent BioDefense Operations Lansing, LLC
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR, SUBCUTANEOUS
Product type
VACCINE
Marketing category
BLA
Application
BLA103821
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64678-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS100 ug/mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Anthrax Vaccines [Chemical/Ingredient]; Live Attenuated Bacillus Anthracis Vaccine [EPC]; Vaccines, Attenuated [Chemical/Ingredient]

Package NDCNDC-11Package
64678-211-01646780211011 VIAL, MULTI-DOSE in 1 CARTON (64678-211-01) / 5 mL in 1 VIAL, MULTI-DOSE (64678-211-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 64678-211 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64678-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64678-211. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.